<DOC>
	<DOC>NCT00657761</DOC>
	<brief_summary>The metabolic effects of T-20 are not completely known, since the drug is used in combination with other antiretroviral agents. A short-term study in healthy volunteers, with a double-blind crossover design vs. placebo will illustrate if there may be some direct metabolic effects without the influence of HIV infection and the concurrent use of other drugs.</brief_summary>
	<brief_title>Metabolic Effects of Enfuvirtide in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Enfuvirtide</mesh_term>
	<criteria>Healthy adult males BMI between 1924.9 kg/m2 No active concomitant clinical conditions Negative HIV, HBV and HCV serologies Negative abuse drug urine test Prior psychiatric illness Prior dyslipemia Alcohol consumption &gt; 30g/day Caffeine consumption &gt; 5 units/day Current smoker Known drug allergies Participation in other drug trials in the previous 3 months No medications in the previous 30 days</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>April 2008</verification_date>
</DOC>